Clinical trials: Chin Retrusion
Chin Augmentation, Chin Retrusion
Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
The primary objective of the study was to demonstrate non-inferiority of Restylane Lyft with Lidocaine versus a comparator-control for augmentation of the chin region to improve the chin profile.
- Trial name
- NCT05777759
- Testing
- Restylane Lyft with Lidocaine, Juvederm Voluma XC
- Where
- 12 sites in United States, Puerto Rico
- Volunteers
- 175 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Chin Retrusion, Chin Augmentation
A Study to Evaluate the Safety and Efficacy of Restylane Defyne for Chin Augmentation and Correction of Chin Retrusion
To demonstrate the effectiveness of Restylane Defyne for chin augmentation and correction of chin retrusion by demonstrating the superiority in responder rates relative to no treatment.
- Trial name
- NCT03624816
- Testing
- Restylane Defyne
- Where
- 11 sites in United States
- Volunteers
- 140 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Chin Retrusion
Restylane Defyne for Correction of Chin Retrusion
This is a randomized, evaluator-blinded, no-treatment controlled study in subjects with Chin Retrusion.
- Trial name
- NCT03597256
- Testing
- Restylane Defyne
- Where
- China
- Volunteers
- 148 people
- Sponsor
- Galderma R&D
Chin Retrusion
A Safety and Effectiveness Study of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation
This is a safety and effectiveness study of JUVÉDERM VOLUMA XC injectable gel for chin augmentation to correct volume deficit in chin retrusion.
- Trial name
- NCT02833077
- Testing
- JUVÉDERM VOLUMA® XC
- Where
- 14 sites in United States
- Volunteers
- 221 people
- Sponsor
- Allergan